Evidence map›Paper›PMID 34749441›Full record

ArticleInternational wound journal2022

Oxymatrine promotes hypertrophic scar repair through reduced human scar fibroblast viability, collagen and induced apoptosis via autophagy inhibition.

Xingwang Deng, Fang Zhao, Dan Zhao, Qing Zhang, Yongzhao Zhu, Qian Chen, Lijuan Qiang, Nan Xie, Jiaxiang Ma, Xiaoliang Pan and 3 more

Open access · goldAbstract read
In one paragraph

Article in International wound journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Observational
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 3 countries.

Xingwang DengSchool of Clinical Medicine, Ningxia Medical University, Yinchuan, China.
Fang ZhaoTissue Organ Bank & Tissue Engineering Centre, General Hospital of Ningxia Medical University, Yinchuan, China.
Dan ZhaoTissue Organ Bank & Tissue Engineering Centre, General Hospital of Ningxia Medical University, Yinchuan, China.
Qing ZhangTissue Organ Bank & Tissue Engineering Centre, General Hospital of Ningxia Medical University, Yinchuan, China.
Yongzhao ZhuTissue Organ Bank & Tissue Engineering Centre, General Hospital of Ningxia Medical University, Yinchuan, China.
Qian ChenSchool of Clinical Medicine, Ningxia Medical University, Yinchuan, China.
Lijuan QiangSchool of Clinical Medicine, Ningxia Medical University, Yinchuan, China.
Nan XieBeijing Engineering Lab for Cell Therapy, Beijing, China.
Jiaxiang MaTissue Organ Bank & Tissue Engineering Centre, General Hospital of Ningxia Medical University, Yinchuan, China.
Xiaoliang PanTissue Organ Bank & Tissue Engineering Centre, General Hospital of Ningxia Medical University, Yinchuan, China.
Yinsheng WuDepartment of Burns and Plastic Surgery, General Hospital of Ningxia Medical University, Yinchuan, China.
Lifeng GuanDepartment of Burns and Plastic Surgery, General Hospital of Ningxia Medical University, Yinchuan, China.
Yan XieTissue Organ Bank & Tissue Engineering Centre, General Hospital of Ningxia Medical University, Yinchuan, China.
Ningxia Medical University · CNNingxia Medical University General Hospital · CNFirst Hospital of Shijiazhuang · CNQueensland University of Technology · AUShanghai Cell Therapy Research Institute · CN

Funding

The Key Research and Development Plan of Ningxia Hui Autonomous Region, Ningxia, China 2019BEG03069the Scientific and Technological Innovation Leader Grant Program, Ningxia, China KJT2015022
6 · The paper itself

Abstract

Scars are common complications of burns and trauma, resulting in mental trauma, physical pain, and a heavy financial burden for patients. Specific and effective anti-scarring drugs are lacking in clinical practice. Phytochemicals are easily accessible, low in toxicity, and have various biological and pharmacological properties. Oxymatrine is a phytochemical that regulates autophagy networks. Autophagy is closely related to the maintenance, activity, differentiation, and life-death of skin fibroblasts during wound repair, which results in pathological scars. We hypothesised that oxymatrine may promote hypertrophic scar repair by inhibiting fibroblast autophagy. In vitro studies showed that inhibition of autophagy by oxymatrine decreased viability and collagen metabolism, and increased apoptosis of human scar fibroblasts (HSFs). In vivo studies showed that inhibition of autophagy by oxymatrine promoted scar repair, resulting in a significantly improved final outcome of the hypertrophic scars, a smaller scar area, decreased epidermal and dermal thickness, and a significant downregulation of CK10, P63, collagen I, α-SMA, and TGF-β1. In summary, oxymatrine promoted hypertrophic scar repair by decreasing HSF viability and collagen, and inducing apoptosis via autophagy inhibition. This study provides a new perspective on the mechanism of hypertrophic burn scar formation, as well as key scientific data for the application of the phytochemical oxymatrine as a new method for the prevention and treatment of hypertrophic scars.

Indexed as

BurnsCicatrix, HypertrophicAlkaloidsApoptosisAutophagyCollagenFibroblastsHumansMatrinesQuinolizinesAlkaloidsCollagenMatrinesoxymatrineQuinolizinesautophagy inhibitionhypertrophic scar remediationoxymatrine

Identifiers

PMID34749441
PMCPMC9284648
OpenAlexW3212508200

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.